Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds (NCT07265791) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds
100 participantsStarted 2026-01-03
Plain-language summary
Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds
Who can participate
Age range
19 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 19 to 75 years
* Voluntarily provided written informed consent
* Moderate to severe symmetrical nasolabial folds (WSRS score 3 or 4 on both sides)
* Agree to discontinue other facial dermatologic treatments (e.g., fillers, botulinum toxin, laser) during the study
* Able to understand instructions and comply with study procedures
Exclusion Criteria:
* Untreated scars or facial skin infections/diseases affecting the mid/lower face within the past year
* History of severe allergy or hypersensitivity to device components
* Facial invasive procedures within the past 6 months (including surgery, laser, botulinum toxin)
* Use of certain medications (anticoagulants, immunosuppressants, steroids) within specified washout periods
* Participation in other interventional clinical trials within 4 weeks before screening or during study
* Non-compliance with contraception requirements or pregnancy/lactation during study
* Deemed unsuitable by investigator for any other reason
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
AE
Timeframe: From adverse event onset through resolution or stabilization, up to 30 days post-study completion
2
SAE
Timeframe: From adverse event onset through resolution or stabilization, up to 30 days post-study completion
3
Solicited local AE
Timeframe: Within 2 weeks after device application